login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TANGO THERAPEUTICS INC (TNGX) Stock News
USA
- NASDAQ:TNGX -
US87583X1090
-
Common Stock
7.14
USD
-0.18 (-2.46%)
Last: 10/10/2025, 9:00:15 PM
7.09
USD
-0.05 (-0.7%)
After Hours:
10/10/2025, 9:00:15 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TNGX Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Present First Clinical Data from TNG260 at Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025
2 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
2 months ago - By: Yahoo Finance
- Mentions:
PANW
CAT
UBS
RNTX
...
Palo Alto upgraded, Li Auto downgraded: Wall Street's top analyst calls
2 months ago - By: The Motley Fool
- Mentions:
GILD
Tango (TNGX) Q2 Revenue Drops 52%
2 months ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
5 months ago - By: Benzinga
Insights into Tango Therapeutics's Upcoming Earnings
2 months ago - By: Zacks Investment Research
- Mentions:
ARCT
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
2 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
2 months ago - By: Zacks Investment Research
- Mentions:
IGMS
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
2 months ago - By: Zacks Investment Research
- Mentions:
KRYS
Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
3 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
4 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer
4 months ago - By: Stocktwits
- Mentions:
SHPH
NVS
MRK
LLY
...
5 Biotech Stocks with Highly Anticipated Pending Results
5 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
5 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
5 months ago - By: Zacks Investment Research
- Mentions:
YMAB
Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates
5 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
5 months ago - By: Zacks Investment Research
- Mentions:
BEAM
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Misses Revenue Estimates
5 months ago - By: Zacks Investment Research
- Mentions:
MIRM
Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
5 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
7 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
8 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights
8 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
8 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference
10 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 months ago - By: Tango Therapeutics, Inc.
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Please enable JavaScript to continue using this application.